Our next immuno-oncology webinar with SelectScience is now available to stream on demand!

We're looking back at the opening of our Discovery Centre and our team's achievements so far.

Using real-time kinetic data to develop a potency bioassay.

Effective IgG1 Fc silencing: characterisation of residual binding and functional activity.

Development of a NK cell expansion protocol for use in assessments of NK-targeting therapeutics.

The Neonatal Fc Receptor (FcRn) shows promising therapeutic potential in autoimmunity and other conditions.

Partnership with lab-on-a-chip startup will help simulate complex disease states and accelerate drug discovery.

Antibody Analytics' in-house SPR experts discuss our custom SPR assay services and answer FAQs!

The partnership promotes collaboration between universities and industries across life science.

Our CSO Dr Agapitos Patakas presents our in vitro T cell exhaustion model.

Research often targets the capabilities of T cells, but B cells also hold therapeutic potential.

We’re excited to work with an organisation that empowers Black ethnic minority workers.